Comparison of anti-hepatitis B virus activities of lamivudine and clevudine by a quantitative assay

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 1, 2003, Pages 324-336

  Abdelhamed, Ayman M ^a   Kelley, Colleen M ^a   Miller, Thomas G ^a   Furman, Phillip A ^a   Cable, Edward E ^a   Isom, Harriet C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CLEVUDINE; LAMIVUDINE; VIRUS DNA;

ANTIVIRAL ACTIVITY; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; DNA SEQUENCE; HEPATITIS B; HEPATOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SOUTHERN BLOTTING; VIRUS DETECTION; VIRUS REPLICATION;

EID: 0037228890     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.1.324-336.2003     Document Type: Article

References (57)

1. Abdelhamed, A. M., C. M. Kelley, T. G. Miller, P. A. Furman, and H. C. Isom. 2002. Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment. J. Virol. 76:8148-8160.
2. Aguesse-Germon, S., S.-H. Liu, M. Chevallier, C. Pichoud, C. Jamard, C. Borel, C. K. Chu, C. Trépo, Y.-C. Cheng, and F. Zoulim. 1998. Inhibitory effect of 2′-fluoro-5-methyl-β-L-arabinofuranosyl-uracil on duck hepatitis B virus replication. Antimicrob. Agents Chemother. 42:369-376.
3. Aldrich, C. E., L. Coates, T. T. Wu, J. Newbold, B. C. Tennant, J. Summers, C. Seeger, and W. S. Mason. 1989. In vitro infection of woodchuck hepatocytes with woodchuck hepatitis virus and ground squirrel hepatitis virus. Virology 172:247-252.
4. Boyce, F. M., and N. L. Bucher. 1996. Baculovirus-mediated gene transfer into mammalian cells. Proc. Natl. Acad. Sci. USA 93:2348-2352.
5. Chu, C. K., F. D. Boudinot, S. F. Peek, J. H. Hong, Y. Choi, B. E. Korba, J. L. Gerin, P. J. Cote, B. C. Tennant, and Y. C. Cheng. 1998. Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent. Antivir. Ther. 3:113-121.
6. Chu, C. K., T. Ma, K. Shanmuganathan, C. Wang, Y. Xiang, S. B. Pai, G.-Q. Yao, J. P. Sommadossi, and Y.-C. Cheng. 1995. Use of 2′-fluoro-5-methyl-β-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus. Antimicrob. Agents Chemother. 39:979-981.
7. Cullen, J. M., S. L. Smith, M. G. Davis, S. E. Dunn, C. Botteron, A. Cecehi, D. Linsey, D. Linzey, L. Frick, M. T. Paff, A. Goulding, and K. Biron. 1997. In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks. Antimicrob. Agents Chemother. 41:2076-2082.
8. Dane, D. S., C. H. Cameron, and M. Briggs. 1970. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet i:695-698.
9. Delaney, W. E., IV, and H. C. Isom. 1998. Hepatitis B replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus. Hepatology 28:1134-1146.
10. Delaney, W. E., IV, T. G. Miller, and H. C. Isom. 1999. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)- β-2′,3′-dideoxy-3′-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA. Antimicrob. Agents Chemother. 43:2017-2026.
11. Dienstag, J. L., E. R. Schiff, T. L. Wright, R. P. Perrillo, H. W. Hann, Z. Goodman, L. Crowther, L. D. Condreay, M. Woessner, M. Rubin, and N. A. Brown. 1999. Lamivudine as initial treatment for chronic hepatitis B in the United States. N. Engl. J. Med. 341:1256-1263.
12. Earnshaw, D. L., T. H. Bacon, S. J. Darlison, K. Edmonds, R. M. Perkins, and R. A. Vere Hodge. 1992. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus. Antimicrob. Agents Chemother. 36:2747-2757.
13. Furman, P. A., M. Davis, D. C. Liotta, M. Paff, L. W. Frick, D. J. Nelson, R. E. Dornsife, J. A. Wurster, L. J. Wilson, J. A. Fyfe, et al. 1992. The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob. Agents Chemother. 36:2686-2692.
14. Ganem, D. 1991. Assembly of hepadnaviral virions and subviral particles. Curr. Top. Microbiol. Immunol. 168:61-83.
15. Ganem, D., and H. E. Varmus. 1987. The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem. 56:651-693.
16. Honkoop, P., R. A. de Man, P. E. Zondervan, and S. W. Schalm. 1997. Histological improvement in patient with chronic hepatitis B virus infection treated with lamivudine. Liver 17:103-106.
17. Hoofnagle, J. H., and A. M. di Bisceglie. 1997. The treatment of chronic viral hepatitis. N. Engl. J. Med. 336:347-356.
18. Hurwitz, S. J., B. C. Tennant, B. E. Korba, J. L. Gerin, and R. F. Schinazi. 1998. Pharmacodynamics of (-)-β-2′,3′-dideoxy-3′-thiacytidine in chronically virus-infected woodchucks compared to its pharmacodynamics in humans. Antimicrob. Agents Chemother. 42:2804-2809.
19. Ilsley, D. D., S. H. Lee, W. H. Miller, and R. D. Kuchta. 1995. Acyclic guanosine analogs inhibit DNA polymerases α, δ, and ε with very different potencies and have unique mechanisms of action. Biochemistry (Moscow). 34:2504-2510.
20. Jarvis, B., and D. Faulds. 1999. Lamivudine: a review of its therapeutic potential in chronic hepatitis B. Drugs 58:101-141.
21. Kamimura, T., A. Yoshikawa, F. Ichida, and H. Sasaki. 1981. Electron microscopic studies of Dane particles in hepatocytes with special reference to intracellular development of Dane particles and their relation with HBeAg in serum. Hepatology 1:392-397.
22. Knowles, B. B., C. C. Howe, and D. P. Aden. 1980. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209:497-499.
23. Kocie, I. 2000. Clevudine University of Georgia/Abbott/Bukwang/Triangle/Yale University. Curr. Opin. Investig. Drugs 1:308-313.
24. Kock, J., and H. J. Schlicht. 1993. Analysis of the earliest steps of hepadnavirus replication genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity. J. Virol. 67:4867-4874.
25. Lai, C. L., R. N. Chien, N. W. Leung, T. T. Chang, R. Guan, D. I. Tai, K. Y. Ng, P. C. Wu, J. C. Dent, J. Barber, S. L. Stephenson, and D. F. Gray. 1998. A one-year trial of lamivudine for chronic hepatitis B. N. Engl. J. Med. 339:61-68.
26. Lenhoff, R. J., and J. Summers. 1994. Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus. J. Virol. 68:4565-4571.
27. Liu, S.-H., K. L. Grove, and Y.C. Cheng. 1998. Unique metabolism of a novel antiviral L-nucleoside analog, 2′-fluoro-5-methyl-β-L-arabinofuranosyluracil: a substrate for both thymidine kinase and deoxycytidine kinase. Antimicrob. Agents Chemother. 42:833-839.
28. Marion, P. L., L. S. Oshiro, D. C. Regnery, G. H. Scullard, and W. S. Robinson. 1980. A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. Proc. Natl. Acad. Sci. USA 77:2941-2945.
29. Mason, W. S., C. Aldrich, J. Summers, and J. M. Taylor. 1982. Asymmetric replication of duck hepatitis B virus DNA in liver cells: free minus strand DNA. Proc. Natl. Acad. Sci. USA 70:3997-4001.
30. Mason, W. S., J. Cullen, G. Moraleda, J. Saputelli, C. E. Aldrich, D. S. Miller, B. Tennant, L. Frick, D. Averett, L. D. Condreay, and A. R. Jilbert. 1998. Lamivudine therapy of WHV-infected woodchucks. Virology 245:18-32.
31. Mason, W. S., M. S. Halpern, J. M. England, G. Seal, J. Egan, L. Coates, C. Aldrich, and J. Summers. 1983. Experimental transmission of duck hepatitis B virus. Virology 131:375-384.
32. Mason, W. S., G. Seal, and J. Summers. 1980. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J. Virol. 36:829-836.
33. Miller, R. H., and W. S. Robinson. 1984. Hepatitis B virus DNA forms in nuclear and cytoplasmic fractions of infected human liver. Virology 137:390-399.
34. Moraleda, G., J. Saputelli, C. E. Aldrich, D. Averett, L. Condreay, and W. S. Mason. 1997. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J. Virol. 71:9392-9399.
35. Nair, V., and T. S. Jahnke. 1995. Antiviral activities of isomeric dideoxynucleosides of D- and L-related stereochemistry. Antimicrob. Agents Chemother. 39:1017-1029.
36. Nicoll, A. J., D. L. Colledge, J. J. Toole, P. W. Angus, R. A. Smallwood, and S. A. Locarnini. 1998. Inhibition of duck hepatitis B virus replication by 9- (2-phosphonylmethoxyethyl) adenine, an acyclic phosphonate nucleoside analogue. Antimicrob. Agents Chemother. 42:3130-3135.
37. Ono, S. K., N. Kato, Y. Shiratori, J. Kato, T. Goto, R. F. Schinazi, F. J. Carrilho, and M. Omata. 2001. The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance. J. Clin. Investig. 107:449-455.
38. Ou, J. H., H. Bao, C. Shih, and S. M. Tahara. 1990. Preferred translation of human hepatitis B virus polymerase from core protein- but not from precore protein-specific transcript. J. Virol. 64:4578-4581.
39. Pai, S. B., S.-H. Liu, Y.-L. Zhu, C.-K. Chu, and Y.-C. Cheng. 1996. Inhibition of hepatitis B virus by a novel L-nucleoside, 2′-fluoro-5-β-L-arabinofuranosyl uracil. Antimicrob. Agents Chemother. 40:380-386.
40. Raney, A. K., C. M. Eggers, E. F. Kline, L. G. Guidotti, M. Pontoglio, M. Yaniv, and A. McLachlan. 2001. Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 α-null hepatitis B virus transgenic mice. J. Virol. 75:2900-2911.
41. Ruiz-Opazo, N., P. R. Chakraborty, and D. A. Shafritz. 1982. Evidence for supercoiled hepatitis B virus DNA in chimpanzee liver and serum Dane particles: possible implications in persistent HBV infection. Cell 29:129-136.
42. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Analysis and cloning of eukaryotic genomic DNA, p. 9.1-9.62. In Molecular cloning, a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
43. Sandig, V., C. Hofmann, S. Steinert, G. Jennings, P. Schlag, and M. Strauss. 1996. Gene transfer into hepatocytes and human liver tissue by baculovirus vectors. Hum. Gene Ther. 7:1937-1945.
44. Santantonio, T., M. Mazzola, T. Iacovazzi, A. Miglietta, A. Guastadisegni, and G. Pastore. 2000. Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine. J. Hepatol. 32:300-306.
45. Seeger, C., J. Summers, and W. S. Mason. 1991. Viral DNA synthesis. Curr. Top. Microbiol. Immunol. 168:41-60.
46. Severini, A., X.-Y. Liu, J. S. Wilson, and D. L. J. Tyrrell. 1995. Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-β-L-2′,3′-dideoxy-3′-thiacytidine. Antimicrob. Agents Chemother. 39:1430-1435.
47. Summers, J., P. M. Smith, and A. L. Horwich. 1990. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J. Virol. 64:2819-2824.
48. Summers, J., P. M. Smith, M. J. Huang, and M. S. Yu. 1991. Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus. J. Virol. 65:1310-1317.
49. Summers, J., J. M. Smolec, and R. Snyder. 1978. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc. Natl. Acad. Sci. USA 75:4533-4537.
50. Tagawa, M., M. Omata, and K. Okuda. 1986. Appearance of viral RNA transcripts in the early stage of duck hepatitis B virus infection. Virology 152:477-482.
51. Tagawa, M., M. Omata, O. Yokosuka, K. Uchiumi, F. Imazeki, and K. Okuda. 1985. Early events in duck hepatitis B virus infection. Sequential appearance of viral deoxyribonucleic acid in the liver, pancreas, kidney, and spleen. Gastroenterology 89:1224-1229.
52. Tine, F., A. Liberati, A. Craxi, P. Almasio, and L. Pagliaro. 1993. Interferon treatment in patients with chronic hepatitis B: a meta-analysis of the published literature. J. Hepatol. 18:154-162.
53. Tuttleman, J. S., C. Pourcel, and J. Summers. 1986. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47:451-460.
54. Wei, Y., J. E. Tavis, and D. Ganem. 1996. Relationship between viral DNA synthesis and virion envelopment in hepatitis B viruses. J. Virol. 70.6455-6458.
55. Weiser, B., D. Ganem, C. Seeger, and H. E. Varmus. 1983. Closed circular viral DNA and asymmetrical heterogeneous forms in livers from animals infected with ground squirrel hepatitis virus. J. Virol. 48:1-9.
56. Wong, D. K., A. M. Cheung, K. O'Rourke, C. D. Naylor, A. S. Detsky, and J. Heathcote. 1993. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann. Intern. Med. 119:312-323.
57. Yamada, G., Y. Sakamoto, M. Mizuno, T. Nishihara, T. Kobayashi, T. Takahashi, and H. Nagashima. 1982. Electron and immunoelectron microscopic study of Dane particle formation in chronic hepatitis B virus infection. Gastroenterology 83:348-356.